Triple-negative breast cancer (TNBC) is a molecular subtype of breast cancer with negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) [28]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.